BrainsWay Ltd. (BWAY), a global leader in noninvasive neurostimulation for mental health, announced a strategic equity financing agreement with Stella MSO, LLC - "Stella Mental Health", a management services organization operating over 20 mental health clinics in the U.S. and Israel, serving more than 30,000 patients.
BrainsWay CEO Hadar Levy stated that this $5 million minority investment in Stella is the first in a series aimed at high-performing providers across the U.S. The initiative seeks to accelerate market access and awareness of innovative treatments like Deep TMS Therapy, while allowing BrainsWay to maintain focus on advancing its clinical technology and supporting customers.
Levy praised Stella's clinical excellence and operational strength, expressing confidence in their ability to scale and deliver impactful patient care. Under the agreement, BrainsWay will receive a minority stake in Stella through a preferred, annually compounding security with a redemption option.
Stella CEO Michael Gershenzon highlighted BrainsWay's strong clinical reputation and described the partnership as a strategic investment to accelerate growth and expand patient access to transformative care.
BrainsWay's CEO Hadar Levy emphasized that the investment in Stella Mental Health is part of a broader strategy to boost access to advanced mental health treatments while keeping focus on clinical innovation. Stella's CEO Michael Gershenzon called the partnership a strategic move to scale growth and improve patient outcomes by expanding access to BrainsWay's technology.
Wednesday, BWAY closed at $10.46, up 2.65%, and traded after hours at $10.67, a 2.01% increase on the Nasdaq Global Market.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.